585
Views
10
CrossRef citations to date
0
Altmetric
Editorials: Cell Cycle Features

Cancer hallmarks sustained by ectopic activations of placenta/male germline genes

, &
Pages 2331-2332 | Received 24 Jun 2013, Accepted 25 Jun 2013, Published online: 11 Jul 2013

References

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
  • Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell 2013; 153:38 - 55; http://dx.doi.org/10.1016/j.cell.2013.03.008; PMID: 23540689
  • Wang J, Emadali A, Le Bescont A, Callanan M, Rousseaux S, Khochbin S. Induced malignant genome reprogramming in somatic cells by testis-specific factors. Biochim Biophys Acta 2011; 1809:221 - 5; http://dx.doi.org/10.1016/j.bbagrm.2011.04.003; PMID: 21530697
  • Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med 2013; 5:86ra66; http://dx.doi.org/10.1126/scitranslmed.3005723; PMID: 23698379
  • Gaucher J, Reynoird N, Montellier E, Boussouar F, Rousseaux S, Khochbin S. From meiosis to postmeiotic events: the secrets of histone disappearance. FEBS J 2010; 277:599 - 604; http://dx.doi.org/10.1111/j.1742-4658.2009.07504.x; PMID: 20015078
  • Gaucher J, Boussouar F, Montellier E, Curtet S, Buchou T, Bertrand S, et al. Bromodomain-dependent stage-specific male genome programming by Brdt. EMBO J 2012; 31:3809 - 20; http://dx.doi.org/10.1038/emboj.2012.233; PMID: 22922464
  • Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 2010; 330:1824 - 7; http://dx.doi.org/10.1126/science.1195481; PMID: 21205669
  • Emadali A, Rousseaux S, Bruder-Costa J, Rome C, Duley S, Hamaidia S, et al. Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers. EMBO Mol Med 2013; http://dx.doi.org/10.1002/emmm.201202034; PMID: 23828858